The institute was present at the 14th MGFA International Conference on Myasthenia and Related Disorders

Partager sur

The 14th International Conference on Myasthenia Gravis and Related Disorders organised by the Myasthenia Gravis Foundation of America (MGFA) took place from 10 to 12 May 2022 in Miami, USA. It brought together the best experts in myasthenia, including the researchers of team 7 “Myasthenia Gravis: Etiology, Physiopathology & Therapeutical Approaches” of the Institute’s Myology Centre for Research: Rozen Le Panse, also a member of the steering committee, Nadine Dragin, Jean-Thomas Vilquin, Sonia Berrih-Aknin, Alexandra Bayer, Edouard Hemery, Anne Charlotte Lefranc and Samy Hamadache, as well as Marius Halliez (MCR team 10, “Neuromuscular Connectivity in Health & Diseases“) and Simone Birnbaum (NIC, Neuromuscular Physiology and Evaluation Laboratory).

Oral presentations:

  • Rozen Le Panse, DR (CRM, team 7, invited speaker): Role of endogenous nucleic acids in interferon type 1 signature in early-onset AChR Myasthenia Gravis
  • Nadine Dragin, CR (CRM, team 7, invited speaker): Targeting IL-23 Amerliorates Thymic and Neuromuscular Defects in Myasthenia Gravis
  • Sonia Berrih-Aknin, émérite (CRM, team 7, invited speaker): Biomarker Response to thymectomy
  • Alexandra Bayer, PhD student (CRM, team 7, selected speaker): Conditioned Mesenchymal Stromal Cells as tools for immunomodulation in Myasthenia Gravis
  • Simone Birnbaum, CR (Neuromuscular Physiology and Evaluation Laboratory, invited speaker): Exercise in MG RCT

Posters:

  • Edouard Hemery, PhD student (CRM, team 7, hightligted poster): Decrease in non-classical monocytes in Myasthenia gravis patients 
  • Anne Charlotte Lefranc, IE & Samy Hamadache, PhD student (CRM, team 7): May IL-17 play a role in skeletal muscle in pathophysiological mechanism in autoimmune Myasthenia gravis? 
  • Sonia Berrih-Aknin (CRM, team 7): Novel biomarkers associated with autoimmune Myasthenia Gravis: a pilot study using two different proteomic approaches
  • Rozen Le Panse (CRM, team 7): Characterization of circulating immune cells in Myasthenia Gravis by mass cytometry revealed dysregulation of innate immune cells
  • Marius Halliez, PhD student (CRM, team 10):  Musk cystein rich domain in autoimmune myasthenic syndrome

 

Access the 14th MGFA International Conference on Myasthenia and Related Disorders program

On the same topic